Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$33.1B
846M shares
52-week range
$32.82 – $50.88
35% from low
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NASDAQ
CS
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.
www.medline.comNo one on the platform currently holds MDLN.
| Institution | Shares | Reported |
|---|---|---|
| The Baupost Groupas of 2026-03-31 | 11,789,156 | $524.6M |
| Renaissance Technologiesas of 2026-03-31 | 143,700 | $6.4M |
No one on the platform has traded MDLN yet.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$UNH $ELV $ABBV $MCK $MDLN if the tech sector rises again it will be good idea to short health sector
View on StockTwits ↗@DrMunch Regardless of the company quality, I don't like the share structure of $MDLN. Held it for a while and felt like exit liquidity for private equity sponsors like Blackstone, Carlyle, and Hellman & Friedman. Always staring down the gun of a secondary public offering to unload over 86 million shares is no fun.
View on StockTwits ↗$CAH Same market cap as $MDLN but has 8x higher revenue. How does this add up?
View on StockTwits ↗$MDLN should be 45+ after earnings!! This thing is a beast of a company!!
View on StockTwits ↗$MDLN is one of the largest medical-surgical supply companies, selling products hospitals and clinics need regardless of the economic cycle, making demand relatively resilient!!
View on StockTwits ↗$MBX bro they are good till 2029 and are really looking like they have been getting down to business there is so much they have going on $SPY this is the one that I wish I would of bought before when I put it in one of my watch lists after trading it and not holding long term. $MDLN
View on StockTwits ↗$MDLN $MAN $SPY long terms looking good this is just the start of all of this. and personally I think Medline will do great. Might even become the new $SNDK
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $31.1B | +10.4% | $1.51 | $1.45–$1.56 | 25.8× | 14 |
| 2027 | $33.6B | +8.0% | $1.66 | $1.59–$1.70 | 23.6× | 15 |
| 2028 | $36.1B | +7.4% | $1.86 | $1.65–$2.09 | 21.0× | 9 |
| 2029 | $38.7B | +7.3% | $2.11 | $2.06–$2.88 | 18.6× | 3 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 1 of the last 2 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-05-06 | $0.30 | $0.33 | +11.8% |
| 2026-02-25 | $0.24 | $0.22 | -7.6% |
| $14.2B |
| — |
| INFUInfuSystem Holdings, Inc. | $9.19 | -5.84% | $185M | — |
| KMTSKestra Medical Technologies, Ltd. | $23.15 | +1.76% | $1.4B | — |
Source: Financial Modeling Prep · peers by sector/industry